Erin Liberto's most recent trade in AVITA Medical Inc was a trade of 35,950 Common Stock done . Disclosure was reported to the exchange on July 1, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
AVITA Medical Inc | Erin Liberto | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 35,950 | 46,450 | - | - | Common Stock | |
AVITA Medical Inc | Erin Liberto | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 20,650 | 20,650 | - | - | Stock Options (Right to Buy) | |
AVITA Medical Inc | Erin Liberto | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 10,500 | 10,500 | - | - | Common Stock | |
AVITA Medical Inc | Erin Liberto | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 6,925 | 6,925 | - | - | Stock Options (Right to Buy) | |
AVITA Medical Inc | Erin Liberto | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 6,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
AVITA Medical Inc | Erin Liberto | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2020 | 6,000 | 24,000 | - | - | Stock Options (Right to Buy) |